Position in ACAD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,638,365
-$2,949,045 QoQ
Shares Held
118,525
-43.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95.49040286859312.ToString("F0")%
Shared 0.ToString("F0")%
None 4.509597131406876.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2021CallValue
$1,290,000
CallShares
50,000
PutValue
$129,000
PutShares
5,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. ACAD ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ACAD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,638,365 | 118,525 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,587,410 | 209,188 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,218,135 | 150,803 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,991,628 | 138,694 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,317,762 | 199,745 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,713,103 | 202,349 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,889,931 | 187,902 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,017,900 | 185,717 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,884,499 | 101,920 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,761,508 | 88,199 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,003,458 | 144,120 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,477,617 | 186,957 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,373,050 | 179,227 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,608,508 | 101,037 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,688,366 | 103,201 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,462,341 | 103,786 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,009,449 | 165,543 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,772,048 | 204,458 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,258,663 | 196,187 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,863,154 | 158,391 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $129,000 | 5,000 | Put | Defined | 2021-05-13 | |
| 2021-03-31 | $3,993,916 | 154,803 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $1,290,000 | 50,000 | Call | Defined | 2021-05-13 | |
| 2020-12-31 | $9,464,929 | 177,047 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $8,313,029 | 201,528 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $10,556,811 | 217,801 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $9,720,076 | 230,061 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||